Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Isoacetoside
2. Isoverbascoside
1. 61303-13-7
2. Isoverbascoside
3. 588ljk42ap
4. [(2r,3r,4s,5r,6r)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
5. Nsc-729649
6. Isoacetoside
7. Unii-588ljk42ap
8. Iso-acteoside
9. Acteoside Isomer
10. Verbascoside,(s)
11. [(2r,3r,4s,5r,6r)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
12. Chembl504873
13. Chebi:192072
14. Dtxsid501317837
15. Hy-n0022
16. Bdbm50386896
17. Mfcd06798947
18. Nsc729649
19. S9128
20. Zinc49898792
21. Akos037514697
22. Ccg-270268
23. Nsc 729649
24. 303i137
25. Q-100709
26. Q27261572
27. ((2r,3r,4s,5r,6r)-6-(3,4-dihydroxyphenethoxy)-3,5-dihydroxy-4-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)tetrahydro-2h-pyran-2-yl)methyl (e)-3-(3,4-dihydroxyphenyl)acrylate
28. (e)-((2r,3r,4s,5r,6r)-6-(3,4-dihydroxyphenethoxy)-3,5-dihydroxy-4-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)tetrahydro-2h-pyran-2-yl)methyl 3-(3,4-dihydroxyphenyl)acrylate
29. .beta.-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-o-(6-deoxy-.alpha.-l-mannopyranosyl)-, 6-((2e)-3-(3,4-dihydroxyphenyl)-2-propenoate)
30. .beta.-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-o-(6-deoxy-.alpha.-l-mannopyranosyl)-6-o-[(2e)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-
31. 1-o-[2-(3,4-dihydroxyphenyl)ethyl]-3-o-(3alpha,4alpha,5beta-trihydroxy-6alpha-methyltetrahydro-2h-pyran-2beta-yl)-6-o-[3-(3,4-dihydroxyphenyl)acryloyl]-beta-d-glucopyranose
32. 2-(3',4'-dihydroxyphenyl)ethyl 6-o-caffeoyl-3-o-(alpha-l-rhamnopyranosyl)-beta-d-glucopyranoside
33. Beta-d-glucopyranoside, 2-(3,4-dihydroxyphenyl)ethyl 3-o-(6-deoxy-alpha-l-mannopyranosyl)-, 6-(3-(3,4-dihydroxyphenyl)-2-propenoate), (e)-
Molecular Weight | 624.6 g/mol |
---|---|
Molecular Formula | C29H36O15 |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 11 |
Exact Mass | 624.20542044 g/mol |
Monoisotopic Mass | 624.20542044 g/mol |
Topological Polar Surface Area | 245 Ų |
Heavy Atom Count | 44 |
Formal Charge | 0 |
Complexity | 936 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?